A detailed history of State Street Corp transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 225,896 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
225,896
Previous 178,663 26.44%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
N/A
47,233 Added 26.44%
225,896 $0
Q2 2024

Aug 14, 2024

BUY
N/A
45,387 Added 34.05%
178,663 $0
Q3 2023

Nov 14, 2023

BUY
N/A
7,300 Added 5.79%
133,276 $0
Q2 2023

Aug 14, 2023

BUY
N/A
40,637 Added 47.62%
125,976 $0
Q1 2023

May 15, 2023

BUY
N/A
85,339 New
85,339 $0

Others Institutions Holding ACRV

About Acrivon Therapeutics, Inc.


  • Ticker ACRV
More about ACRV
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.